Revenue segments as reported by the company.

Net revenue, before excise taxes

Excise taxes

Revenue Segments

Gross Profit, Operating Income, and Net Income as a percentage of Revenue

Gross Margin

Operating Margin

Profit Margin

Margins

An operating expense is an expense a business incurs through its normal business operations. Often abbreviated as OPEX.

Sales and marketing

Research and development

General and administrative

Restructuring costs

Share-based payments

Depreciation and amortization

Impairment loss on goodwill and indefinite-lived intangible assets

Impairment loss on long-lived assets

Operating Expenses

Year over year growth in Revenue and Operating Expenses.

Revenue Y/Y

OpEx Y/Y

Growth

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company's officers and insiders.

Outstanding Shares

Market Cap

Also known as Price/Sales Ratio. Calculated using Average market cap for the quarter / Annualized quarterly revenue.

Revenue Multiple

Cronos Group

Cronos Group, Inc. engages in the production and distribution of cannabis. Its brands include PEACE NATURALS, COVE, Spinach, Lord Jones, and PEACE+. The company was founded by Lorne Michael Gertner and Paul Rosen on August 21, 2012 and is headquartered in Toronto, Canada.

Earnings data Q4 2020

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Cronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the Canada and Israel segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.

Altria

Analysts continue to pile on Cronos with negative views. Don't overlook these potential catalysts for the pot stock, though.

Everybody's Hating on Cronos Group -- but Here Are 3 Reasons the Pot Stock Could Double

Aurora Cannabis

Canopy Growth

Canadian pot sales in February were 13% lower than in December.

Uh-Oh! Canadian Marijuana Sales Have Declined 2 Straight Months

Aphria

HEXO Corp

Scotts Miracle-Gro

Tilray Brands

Cannabis stocks had a huge showing on Wall Street this past fall.

Short Sellers Hazy on Picking Cannabis Stocks

CannTrust Holdings

Constellation Brands

Shelf Offerings Could Cripple These 2 Pot Stocks in the Near Term

Village Farms International

Have pessimists had a change of heart, or is this simply profit-taking?

2 Marijuana Stocks With Rapidly Declining Short Interest

This marijuana stock has been initiated at, or downgraded to, the equivalent of a sell rating four times in less than two months.

The Most Hated Pot Stock Logs Another Sell Rating

Perrigo

Molson Coors Brewing

Cannabis companies remain "trader" stocks.

Cannabis Stocks: The Massive Gap Between Fact And Fantasy

Curaleaf Holdings, Inc.

Green Thumb Industries Inc.

MedMen Enterprises Inc.

Trulieve Cannabis Corp.

There are some surprising marijuana stocks at the top and bottom of this list.

Which Pot Stocks Have the Highest Gross Margin?

Nearly every candidate support federal legalization of recreational marijuana and many call for expunging federal charges for those prosecuted.

Most 2020 Democratic presidential candidates agree on recreational marijuana: Legalize it

AllianceBernstein Hld

AB vs. CRON: Which Stock Is the Better Value Option?

GW Pharmaceuticals

The world is "going green" at an increasingly rapid pace.

16 Marijuana 4/20 Facts That Show How Far the Cannabis Movement Has Come

Surprise! Canopy Growth isn't No. 1 (or 2).

These 15 Pot Stocks Will Generate the Highest Sales in 2020

The cannabis sector received one of its biggest votes of confidence yet from Wall Street on Wednesday when a top firm initiated coverage on four cannabis stocks.

Bank Of America Initiates Coverage On Cannabis Stocks, Names Surprising Top Pick

Merrill Lynch has started coverage of the legalized cannabis industry with a mostly positive view.

Merrill Lynch Jumps on Legalized Cannabis Train, Sees Large Potential Upside

Canopy Growth's next quarterly update might not be nearly as rosy as its last one. And the situation could be even worse for other marijuana producers.

Why 1 Analyst Just Slashed Revenue Estimates for Canopy Growth -- and What It Could Mean for Other Marijuana Stocks

The third largest marijuana stock by market cap has its work cut out for it.

3 Things Cronos Group Needs to Do to Catch Its Competitors

Could the reasons behind Aphria's dismal Q3 results bite Aurora Cannabis, Canopy Growth, and others in their next quarterly updates?

What Aphria's Poor Performance Could Mean for Other Canadian Marijuana Stocks

Without a company name attached to these metrics, are pot stocks really an attractive investment opportunity?

Can You Guess the Identity of These Marijuana Stocks?

Quest Diagnostics' Drug Testing Index highlights a potentially worrisome trend.

Should We Blame Marijuana for a 14-Year High in Positive Work-Related Drug Tests?

Profits could be a lot tougher to come by than investors realize.

Earnings Estimates Are Tumbling for These Pot Stocks

Two out of three Americans favor legalizing marijuana. So, why hasn't that happened yet?

Why Is Legalizing Pot Proving So Difficult in the United States?

Cronos group, a vertically integrated Canadian marijuana company, has seen its stock price rise close to 3x over the last year, driven by the legalization of recreational pot in Canada and also by a $1.8 billion investment from Marlboro cigarette maker Altria group.

What Are The Key Risks Cronos Group Faces?

Cannabis stocks had a huge showing on Wall Street this past fall. In fact, most of the news flow surrounding these stocks had investors pouring money into them. Some of the stocks even doubled or tripled in value in this time.

News for Cronos Group Stock (CRON)